UK-based startup Pangea Botanica develops PangeAI, an AI-powered platform to accelerate drug discovery and development. It maps the chemical composition of plants and creates a diverse dataset of natural products to match compounds. The platform also predicts chemical properties, modes of action, and synergistic effects. By combining AI, metabolomics, and cheminformatics, PangeAI enables the scalable discovery of nature-inspired therapeutics. It also assists in the proposal of lead candidates for development, thereby enhancing the development of new and existing compounds.